Trade KYMR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kymera Therapeutics, Inc. (KYMR) is trading at US$117.75, down 0.62% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$9.96B. Over the past 52 weeks, KYMR has traded between US$47.90 and US$130.05. On Syfe you can trade KYMR with $0 commission and add it to your watchlist.
| Previous close | US$118.48 |
|---|---|
| Market cap | US$9.96B |
| 52-week range | US$47.90 – US$130.05 |
| Volume | 1.9M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of human diseases through the development of innovative, highly differentiated medicines. It focuses on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation system. The company leverages targeted protein degradation (TPD) to develop medicines that address critical health challenges and have the potential to significantly improve patients lives. Its pipeline emphasizes oral small-molecule degraders, offering a new generation of convenient and highly effective therapies. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.
Year: 2020
Kymera Therapeutics Q2 Net Loss Narrows, Collaboration Revenue Rises
Aug 5, 12:39 PM · MT Newswires
--Earnings Flash (KYMR) Kymera Therapeutics Posts Q2 Loss $0.62 a Share, vs. FactSet Est of $0.71 Loss
Aug 5, 11:13 AM · MT Newswires
-- Earnings Flash (KYMR) Kymera Therapeutics, Inc. Reports Q2 Collaboration Revenue $65.0M, vs. FactSet Est of $32.8M
Aug 5, 11:05 AM · MT Newswires
Kymera Therapeutics, Inc. (KYMR) stock is trading at US$117.75, -0.62% from the previous close of US$118.48.
The market cap for Kymera Therapeutics, Inc. (KYMR) stock is approximately US$9.96B.
The 52-week high for Kymera Therapeutics, Inc. (KYMR) stock is US$130.05.
The 52-week low for Kymera Therapeutics, Inc. (KYMR) stock is US$47.90.
Kymera Therapeutics, Inc. (KYMR) does not currently pay a dividend.
Stay on top of KYMR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
